Skyscape Web Viewer : TNM Cancer Staging System : Main Index

View All
Norepinephrine
North American Neuroendocrine Tumor Society (NANETS) Neuroendocrine Tumors of the Colon and Rectum Neuroendocrine Tumors of the Jejunum and Ileum
Novel oral anticoagulation agents (NOACs), for stroke
NPC
NYHA
OAC
OALs
Observed and overall survival rates for 1,278 patients with urethral cancer classified by the current AJCC staging classification
Observed melanoma-related overall Kaplan-Meier survival rates for metastatic primary choroidal and ciliary body melanomas
Observed melanoma-related overall Kaplan-Meier survival rates for nonmetastatic primary choroidal and ciliary body melanomas3
Observed survival rates for 21,904 cases with carcinoma of the corpus uterus
Obturator lymph nodes cervix uteri fallopian tube ovary and primary peritoneal carcinoma penis prostate Vagina
Octreoscan imaging Neuroendocrine Tumors of the Appendix Neuroendocrine Tumors of the Colon and Rectum Neuroendocrine Tumors of the Jejunum and Ileum Neuroendocrine Tumors of the Pancreas Neuroendocrine Tumors of the Stomach
Octreotide Adrenal Neuroendocrine Tumors Neuroendocrine Tumors of the Duodenum and Ampulla of Vater Neuroendocrine Tumors of the Jejunum and Ileum Neuroendocrine Tumors of the Pancreas Thyroid: Medullary
Ocular adnexal lymphomas (OALs)
Ocular surface squamous neoplasia
OGTT
Okuda staging system
Omentectomy
Oncotype Dx(Register TradeMark)
Ophthalmic Oncology Task Force (OOTF) International Survey
Oral anticoagulation (OAC) therapy for stroke Introduction to Soft Tissue Sarcoma
Oral cancer
Oral cavity cancer
Oral contraceptives cervical cancer and endometrial cancer and ovarian cancer and
Oral glucose tolerance test (OGTT)
Orbital Sarcoma
Oropharyngeal squamous cell cancer
Oropharynx HPV-mediated carcinogenesis (see Human papillomavirus (HPV)-related squamous cell carcinoma of the oropharynx (HPV-OPSCC)) p16-negative squamous carcinomas\|prognostic factor p16-negative squamous carcinomas\|regional lymph nodes p16-negative squamous carcinomas\|risk assessment models p16-negative squamous carcinomas\|T1 tumors p16-negative squamous carcinomas\|T2 tumors p16-negative squamous carcinomas\|T3 tumors p16-negative squamous carcinomas\|T4a tumor p16-negative squamous carcinomas\|T4b tumor p16-negative squamous carcinomas\|Zubrod/ECOG performance scale
Osteosarcoma appendicular skeleton pelvis spine